Paternal exposure to methotrexate and pregnancy outcomes

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 628-632

  Beghin, Delphine ^a   Cournot, Marie Pierre ^a   Vauzelle, Catherine ^a   Elefant, Elisabeth ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Methotrexate; Paternal exposure; Pregnancy outcome

Indexed keywords

AZATHIOPRINE; ETANERCEPT; ETRETIN; HYDROXYCHLOROQUINE; INFLIXIMAB; LAMOTRIGINE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RETINOIC ACID; VINCRISTINE;

ADRENAL TUMOR; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LEUKEMIA; LIVE BIRTH; LYMPHOMATOID PAPULOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SARCOIDOSIS; SPONTANEOUS ABORTION; TREATMENT DURATION;

ADULT; FEMALE; FERTILIZATION; FOLIC ACID ANTAGONISTS; HUMANS; IMMUNE SYSTEM DISEASES; MALE; METHOTREXATE; MIDDLE AGED; PATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 79953318781     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100600     Document Type: Article

References (24)

1. Reich EW, Cox RP, Becker MH, Genieser NB, McCarthy JG, Converse JM. Recognition in adult patients of malformations induced by folic-acid antagonists. Birth Defects Orig Arctic Ser 1978;14:139-60. (Pubitemid 9069975)
2. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997;40:971-3. (Pubitemid 27200016)
3. Elefant E, Boyer M, Boyer P, Galliot B, Roux C. Teratogenic Agent Information Centre: fifteen years of counseling and pregnancy follow-up. Teratology 1992;46:35-44.
4. EUROCAT. Minor anomalies for exclusion. [Internet. Accessed Nov 22, 2010]. 2005. Available from: http://www.eurocat-network.eu/content/EUROCAT-New- List-of-Minor-Anomalies.pdf
5. Griggs LR, Schwartz DA. Successful paternity of a healthy child while taking methotrexate for Crohn's disease. Am J Gastroenterol 2006;101:2893-4. (Pubitemid 44902676)
6. Lamboglia F, D'Inca R, Oliva L, Bertomoro P, Sturniolo GC. Patient with severe Crohn's disease became a father while on methotrexate and infliximab therapy. Inflamm Bowel Dis 2009;15:648-9.
7. Ostensen M, von Esebeck M, Villiger PM. Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease. J Rheumatol 2007;34:1266-9. (Pubitemid 46898107)
8. Frank L, Lichtman H, Biro L, Petrou P. Experiences with methotrexate in psoriasis. Dermatologica 1968;137:87-96.
9. Perry WH. Methotrexate and teratogenesis. Arch Dermatol 1983;119:874-5.
10. Weinstein GD. Methotrexate. Ann Intern Med 1977;86:199-204.
11. Paschou S, Voulgari PV, Vrabie IG, Saougou IG, Drosos AA. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol 2009;36:351-4.
12. Matthews JH, Wood JK. Male fertility during chemotherapy for acute leukemia. N Engl J Med 1980;303:1235. (Pubitemid 11207592)
13. Hinkes E, Plotkin D. Reversible drug-induced sterility in a patient with acute leukemia. JAMA 1973;223:1490-1.
14. Kroner TH, Tachumi A. Conception of normal child during chemotherapy of acute lymphoblastic leukaemia in the father. Br Med J 1977;1:1322-3.
15. Koehler M, Waldherr R, Ludwig R, Heinrich U, Brandeis WE. Effects of methotrexate on rabbit testes. Part 1: Morphological changes. Pediatr Hematol Oncol 1986;3:325-34.
16. Riccardi R, Vigersky RA, Barnes S, Bleyer WA, Poplack DG. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res 1982;42:1617-9. (Pubitemid 12103345)
17. Kasahara Y, Nakai Y, Miura D, Yagi K, Hirabayashi K, Makita T. Mechanism of induction of micronuclei and chromosome aberrations in mouse bone marrow by multiple treatments of methotrexate. Mutat Res 1992;280:117-28.
18. Melnyk J, Duffy DM, Sparkes RS. Human mitotic and meiotic chromosome damage following in vivo exposure to methotrexate. Clin Genet 1971;2:28-31.
19. Jensen MK, Nyfors A. Cytogenetic effects of methotrexate on human cells in vivo: comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by the micronucleus test. Mutat Res 1979;64:339-43. (Pubitemid 10223178)
20. Boice JD Jr, Tawn EJ, Winther JF, Donaldson SS, Green DM, Mertens AC, et al. Genetic effects of radiotherapy for childhood cancer. Health Phys 2003;85:65-80. (Pubitemid 36706042)
21. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998;62:45-52. (Pubitemid 28093833)
22. O'Flaherty C, Hales BF, Chan P, Robaire B. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril 2010;94:1374-9.
23. Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980;116:215-7. (Pubitemid 10176570)
24. Estop AM. Sperm chromosome studies in patients taking low dose methotrexate [abstract]. Am J Hum Genet 1992;51:A314.